--- title: "Reshape ApS – CVR 40056173, financials and ownership" description: "Reshape ApS (CVR 40056173): Reshape is a biotechnology software company powering laboratories with experiment-driven discovery, automated data capture, AI-powered assay analysis, and standardized QC testing workflows." canonical_url: "https://datapublica.dk/en/companies/40056173-reshape-aps" locale: "en" route_type: "company_overview" robots: "index,follow" --- # Reshape ApS Reshape ApS \(CVR 40056173\): Reshape is a biotechnology software company powering laboratories with experiment-driven discovery, automated data capture, AI-powered assay analysis, and standardized QC testing workflows. CVR number: 40056173 ## Company details - **CVR number:** 40056173 - **Status:** Aktiv - **Address:** Østbanegade 55 1 th, 2100, København Ø - **Legal form:** Anpartsselskab \(ApS\) - **Founded:** Nov 23, 2018 - **Employees / FTEs:** 54 / 49 - **Production units:** 1 - **Website:** https://reshapebiotech.com/ - **Instagram:** @reshapebiotech - **LinkedIn:** reshape-biotech - **LEI:** 984500AI60637K590690 ## Description Reshape is a biotechnology software company powering laboratories with experiment-driven discovery, automated data capture, AI-powered assay analysis, and standardized QC testing workflows. Reshape helps laboratories design experiments, automatically capture and structure experimental data, analyze assays with AI, and uncover performance trends across experimental parameters. ### Company's own description on virk.dk Reshape ApS' main activities are to develop, produce, and sell the next generation of lab automation robots as well as any related business. ### Products & services Experiment-driven discovery platform • Automated imaging and data capture • AI-powered assay analysis • Secure cloud collaboration and experimental data management • Standardized QC testing workflows • Predictive models for experimental data ### Industries Biotechnology • Laboratory software • Scientific data analysis ### Customer types Laboratories • Next-generation startups • Industry companies ## Analysis by AI ✨ The 2025/26 accounts show a loss of DKK 42.6 million, compared with DKK 35.6 million the previous year, while equity increased from DKK 36.6 million to DKK 75.5 million. The company reported growth and significant investment in the continued development of its services. In July 2026, Reshape ApS had 54 employees and 49 full-time equivalents \(FTE\); in July 2023, the figures were 20 employees and 18 FTE. Since 4 March 2021, [Reshape Biotech Inc.](https://datapublica.dk/en/participants/pid_owner_enhed_4008802467-reshape-biotech-inc) of the United States has been Reshape ApS’s direct legal owner, with a 100% ownership interest and 100% of the voting rights. [NPF Technologies Holding ApS](https://datapublica.dk/en/companies/45290131) currently owns 100% of [NPF TECHNOLOGIES ApS](https://datapublica.dk/en/companies/33243731). NPF TECHNOLOGIES ApS owns 66.67–89.99% of [Wild Radicals Holding ApS](https://datapublica.dk/en/companies/46012577), with 66.67% of the voting rights; this interest in Wild Radicals Holding is not an ownership interest in Reshape ApS. AI-generated texts are based on registered information, which may be delayed or incomplete. Errors may occur. ## Activities and industry - Forskning og eksperimentel udvikling inden for naturvidenskab og teknik - 721000 — Forskning og eksperimentel udvikling inden for naturvidenskab og teknik ## Latest financial period - **Reporting period:** 2025/26 \(1 Apr 2025 - 31 Mar 2026\) - **Currency:** DKK - **Gross profit:** 5,310,622 - **Profit after tax:** -42,643,506 - **Assets:** 87,778,096 - **Equity:** 75,515,117 ## People | Person | Roles | Titles | | --- | --- | --- | | [Carl-Emil Grøn Fuglesang](https://datapublica.dk/en/people/pid_entity_4008047916-carl-emil-gr-n-fuglesang) | Management | DIREKTØR | | [Daniel Storgaard](https://datapublica.dk/en/people/pid_entity_4005998312-daniel-storgaard) | Management | DIREKTØR | | [Magnus Nyborg Madsen](https://datapublica.dk/en/people/pid_entity_4003843595-magnus-nyborg-madsen) | Management | DIREKTØR | ## Auditor | Audit firm | Auditor | Role | From | | --- | --- | --- | --- | | KPMG | Simon Vinberg Andersen | State Authorised Public Accountant | Jul 15, 2026 | | KPMG | — | Statsautoriseret Revisionspartnerselskab | Jul 15, 2026 | ## Contact ### From [cvr.dk](https://datacvr.virk.dk/) Advertising protected Contact details from CVR must not be used for direct marketing when the entity is advertising protected. The protection does not cover details collected from the company’s own website. The general marketing rules still apply. [Read more at the Danish Business Authority](https://virksomhedsguiden.dk/content/ydelser/faa-reklamebeskyttet-din-virksomhed-i-cvr/3337006d-3b93-4bb0-bc08-82a0915c0332/) Protected entities: Company; Reshape ApS · Østbanegade 55 1 th · P-1024171783 | Contact | Phone | Email | | --- | --- | --- | | Company | 4292\*\*\*\* [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F40056173-reshape-aps) | co\*\*\*\*\*@reshapebiotech.com [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F40056173-reshape-aps) | Branches \(1\) Reshape ApS · Østbanegade 55 1 th · P-1024171783 | Contact | Phone | Email | | --- | --- | --- | | Company | 4033\*\*\*\* [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F40056173-reshape-aps) | — | ### From [reshapebiotech.com](https://reshapebiotech.com/) | Contact | Phone | Email | | --- | --- | --- | | Main | — | co\*\*\*\*\*@reshapebiotech.com [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F40056173-reshape-aps) | | Support | — | su\*\*\*\*\*@reshapebiotech.com [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F40056173-reshape-aps) | ## Legal owners ### Current | Owner | Ownership | Voting rights | From | | --- | --- | --- | --- | | OwnerReshape Biotech Inc. | Ownership100 % | Voting rights100 % | FromMar 4, 2021 | ### Previous | Owner | Ownership | Voting rights | From | To | | --- | --- | --- | --- | --- | | OwnerNPF TECHNOLOGIES ApS | Ownership5–9.99 % | Voting rights5 % | FromMay 25, 2020 | ToMar 4, 2021 | | OwnerGron Industries ApS | Ownership25–33.32 % | Voting rights25 % | FromAug 23, 2019 | ToMar 4, 2021 | | OwnerDaniel Storgaard Holding ApS | Ownership25–33.32 % | Voting rights25 % | FromNov 23, 2018 | ToMar 4, 2021 | | OwnerMagnus Nyborg Madsen Holding ApS | Ownership25–33.32 % | Voting rights25 % | FromNov 23, 2018 | ToMar 4, 2021 | ## Ultimate owners [View ownership diagram](https://datapublica.dk/en/companies/40056173-reshape-aps/portfolio) | Name | Ownership through | Calculated ownership | | --- | --- | --- | | Reshape Biotech Inc. | Direct | 100 % | ## Company pages - [Overview](https://datapublica.dk/en/companies/40056173-reshape-aps) - [Financial report](https://datapublica.dk/en/companies/40056173-reshape-aps/financials) - [Risk](https://datapublica.dk/en/companies/40056173-reshape-aps/risk) - [Timeline](https://datapublica.dk/en/companies/40056173-reshape-aps/timeline) - [Ownership and relations](https://datapublica.dk/en/companies/40056173-reshape-aps/portfolio) - [Production units](https://datapublica.dk/en/companies/40056173-reshape-aps/production-units) - [Gazelle](https://datapublica.dk/en/companies/40056173-reshape-aps/gazelle) - [Investments](https://datapublica.dk/en/companies/40056173-reshape-aps/investments) - [Company website](https://reshapebiotech.com/) ## Official sources - [Official CVR record on Virk](https://datacvr.virk.dk/enhed/virksomhed/40056173) - [Official LEI record at GLEIF](https://www.gleif.org/)